Clinical trial
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's…
NCT00286897 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00286897 |
|---|---|
| Title | The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations |
| Official title | A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | E2007 |
| Enrollment | 702 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Nov 3, 2015 |
| Countries | Austria, Belgium, Czechia, Estonia, France, Germany, Hungary, Israel, Italy, Lithuania, Poland, Portugal and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: